Paroxysmal epileptiform abnormalities on EEG are the hallmark of epilepsies, but it is uncertain to what extent epilepsy and background EEG oscillations share neurobiological underpinnings. Confounding factors, including the heterogeneous etiology of epilepsies and medication effects hamper studies on background brain activity in people with epilepsy. This limitation may be partly overcome by assessing the genetic overlap between epilepsy and EEG power spectra based on genome-wide association studies (GWASs). We used the summary statistics of the recently published EEG (n=8,425) and epilepsy (n=37,021) GWASs to compute estimates of genetic overlap between EEG power spectra and epilepsy subtypes using linkage disequilibrium score regression (LDSC) and polygenic risk scoring (PRS). We found significant genetic correlations between genetic generalized epilepsy (GGE) and EEG beta power (rg=0.44; p=0.01) and between GGE and theta power (rg =0.25; p=0.02), which were replicated in an independent GGE cohort. Supporting this finding, beta and theta powers' PRSs were both strongly and positively associated with generalized epilepsy (pvalues ranging from 5.3x10 -8 to 8.5x10 -4 ), suggesting that genetic predisposition to GGE and to altered background brain activity partially overlap. All PRS directions of effect were replicated in an independent cohort of people with epilepsy and controls (n=25,303; p=0.023).
Introduction
The power of oscillations in background EEG is a highly stable and heritable human trait (Smit et al., 2005) . It is easily acquired and can be automatically analyzed by software, rather than subjective interpretation. Epilepsy is fairly heritable and is characterized by altered brain excitability (Thomas and Berkovic, 2014; Devinsky et al., 2018) . Oscillatory activity is believed to serve an essential role in cortico-thalamic functioning, and can be measured as power of oscillations in background EEG at different broad-band frequencies (Steriade, 2000) . Neurophysiological relationships between background EEG and generalized epileptiform discharges have been well described (Gloor, 1978 (Gloor, , 1979 Gloor and Fariello, 1988; Steriade, 2005) , providing a rationale to explore the shared neurobiological basis between epilepsy as a disorder of excitability and oscillatory power as a measure of corticothalamic function.
Here, we therefore assessed whether oscillatory background EEG is genetically correlated with focal and generalized epilepsy. The association between genetic variants and background brain activity was previously investigated in a sizeable genome-wide association study (GWAS) on subjects without epilepsy (Smit et al., 2018) . We combined this data with a recently published large GWAS of epilepsy (International League Against Epilepsy Consortium on Complex, 2018), to examine genetic correlations between several types of epilepsy and oscillatory brain activity across frequency bands (delta: ). Next, we utilized polygenic risk scoring to assess whether patients with GGE have a genetic predisposition towards altered background brain activity. We then replicated genetic correlation and polygenic analyses using an independent cohort. Furthermore, we meta-analyzed both EEG and epilepsy traits to assess pleiotropic signals. Finally, we performed Mendelian Randomization to gain insight into possible causal relationships between genetic variants associated with epilepsy and those associated with background EEG. We thus provide converging evidence for consistent cross-trait genetic overlap between epilepsy and background EEG.
Materials and methods

Study population: discovery dataset
The participants derived from the epilepsy GWASs (International League Against Epilepsy Consortium on Complex, 2018) for the current analyses were Caucasian subjects.
Case/control ascertainment and diagnostic criteria were previously reported (International League Against Epilepsy Consortium on Complex, 2018). As described previously (International League Against Epilepsy Consortium on Complex, 2018), epilepsy specialists diagnosed patients and ascertained phenotypic subtypes. Population-based datasets, some of which had been screened to exclude neurological disorders, were used as controls.Summary statistics from the recent epilepsy GWAS conducted by the ILAE Consortium on Complex Epilepsies GWAS were available for n=12,803 cases (suffering from either focal or generalized epilepsy) and 24,218 controls (International League Against Epilepsy Consortium on Complex, 2018). From those participants the following subjects were excluded for those analyses requiring individual-level genotype data: Finnish ancestry (none had GGE) and the subset of the EPICURE-SP1 cohort that lacked informed consent for the current analyses, resulting in subject-level genotype data being available for 11,446 patients with epilepsy and 22,078 controls. Subjects with epilepsy were stratified into GGE (n=3,122) and focal epilepsy (n=8,324); GGE was further subdivided into childhood absence epilepsy (CAE; n=561), juvenile absence epilepsy (JAE; n=311), juvenile myoclonic epilepsy (JME; n=1,000) and generalized tonic-clonic seizures only (GTCS only; n=195). GGE subtype information was not available for 1055 patients.
We downloaded summary statistics of the ENIGMA-EEG GWAS of resting state oscillation power in the delta (1-3 Hz), theta (4-8 Hz), alpha (8-12 Hz), and beta (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) bands (Smit et al, 2018) at the vertex (Cz) electrode (n=8,425 participants). In this study, subjects with a history of neurological illness, including epilepsy, were excluded (Supplemental methods).
Approval for the source studies was obtained by all relevant institutional review boards and all study participants provided written informed consent according to the Declaration of Helsinki.
Replication dataset
To replicate our findings, we used data from the Epi25 collaborative (http://epi-25.org/). This cohort currently constitutes 4,851 people with epilepsy, of whom 2,612 have focal epilepsy and 2,239 have GGE (no data on GGE subtypes were available). The cases were matched to a total of 20,428 controls from the Partners Healthcare Biobank (n=14,857), the Epi25 collaborative (n=210), the Genetics and Personality consortium (n=456), and an in-house project on inflammatory bowel disease (n=4,905). The cohorts were genotyped on the Illumina Global Screening Array, with the exception of the Partners Healthcare Biobank participants, who were genotyped on the Illumina Multi-Ethnic Screening Array. Approval was obtained by all relevant institutional review boards and all study participants provided written informed consent according to the Declaration of Helsinki.
Genetic correlation analyses
Genetic correlations between epilepsy subtypes and oscillatory brain activity were computed using bivariate linkage-disequilibrium score regression (LDSC) (Bulik-Sullivan et al., 2015) .
For these analyses, as no individual-level genotype data were available from the EEG dataset, we used published summary statistics of the EEG frequency bands (alpha, beta, delta and theta; n=8,425 participants) and the epilepsy subtypes (focal, GGE, CAE, JAE, JME and GTCS only; n=12,803 cases suffering from either focal or generalized epilepsy and 24,218 controls) from the ILAE consortium as a discovery dataset (International League Against Epilepsy Consortium on Complex, 2018). For LDSC replication analyses, we used unpublished data from the Epi25 collaborative (http://epi-25.org/; n=4,851 people with epilepsy and 20,428 controls). For discovery and replication LDSC analyses, default settings of LDSC were used, with pre-computed LD score weights derived from the European subset of the 1000 Genomes project (Genomes Project et al., 2015) . The significance threshold was Bonferroni-corrected for the two epilepsy subtypes studied (GGE and focal) but not for the EEG power spectra, since these were all highly correlated at p<10 -17 (Supplemental Table 1 ), resulting in a significance threshold of p=0.05/2=0.025.
Polygenic risk score (PRS) analyses
For PRS analyses we used individual-level genotype data derived from the epilepsy GWAS (n=11,446 patients with epilepsy and 22,078 controls, International League Against Epilepsy Consortium on Complex, 2018) and summary statistics from the EEG GWAS (n=8,425; Smit et al., 2018) . Quality control was performed as reported in the published epilepsy GWAS (International League Against Epilepsy Consortium on Complex, 2018). We then added a genotype filter for call rate >0.99 and the exclusion of genetically related subjects to allow for highly conservative PRS estimates. Genetic inter-relatedness was calculated with KING (Manichaikul et al., 2010) and one subject from each pair with third-degree or higher relatedness (kinship coefficient >0.0442) was excluded. PRSice (Euesden et al., 2015) was used with default settings to assess whether subjects with epilepsy have different EEG frequency power PRSs compared to controls. In brief, to each SNP we assigned a weight proportional to its association in the four EEG GWASs (alpha, beta, delta and theta). Next, individual PRSs were calculated as the sum of weighted effect alleles for every subject from the epilepsy cohort. These PRSs were standardized with a Z-score transformation . SNPs were pruned to a subset of genetically uncorrelated SNPs (linkage disequilibrium R 2 <0.1) and PRS values were calculated using a number of different P-value thresholds (Pts) from 0.0001 to 0.5. Next, logistic regression analyses, corrected for sex and 10 genetic ancestry principal components, were performed to assess the association of these PRS scores with GGE. The PRSs with the highest association with GGE was chosen as the 'best-fit', after which logistic regression analyses were repeated to assess the association of this PRS with the other epilepsy subtypes. We used a conservative p<0.001 significance threshold to correct for multiple comparisons, as recommended for PRSice (Euesden et al., 2015) . Δ Explained variance represented by the Nagelkerke R 2 was computed using a logistic regression of the PRS, subtracted by the baseline model (covariates only: sex and 4 PCs). We then repeated the analyses in the independent Epi25 cohort. This dataset contained approximately one-third fewer GGE cases than the discovery cohort, providing insufficient power to exactly replicate our discovery PRS findings. We therefore performed quasi-replication using a one-sample test of the proportion to assess concordance effect directions between discovery and replication PRS analyses, computing z-scores that were converted into p-values:
where the p = the sample proportion; H0 represents the null hypothesis: p = p0; and the alternative hypothesis H1: p ≠ p0.
Meta-analysis, Gene-based testing and Gene expression analysis
We found the strongest genetic correlation between GGE and beta oscillations, leading us to meta-analyze the beta oscillation GWAS (Smit et al., 2018) presence of these DEGs in the top 250 genes from the gene-based analysis was then performed using the hypergeometric test. We selected 8 brain tissues (excluding cerebellar tissues) with the addition of whole blood and spleen gene expression for comparison purposes.
To functionally annotate the GWAS meta-analysis results, we used S-Predixcan, seeking to elucidate the tissue-specific expression pathways of the genes using the all GTEx cortical brain tissues (Gamazon et al., 2015; Barbeira et al., 2018) . S-PrediXcan may have increased power to detect significant gene -phenotype associations. S-PrediXcan combines genetic variants in a sparse elastic net prediction model and is based on the GTEx genotype -expression database and is available online (http://https://github.com/hakyimlab/MetaXcan).
Using the precomputed models, PrediXcan imputes gene expression in a specific-tissue manner in subjects with genomic SNP data available. These gene-expression levels are then associated with the trait of interest. S-PrediXcan is the extension of Predixcan that uses only summary statistics, thus avoiding the need for individual level genomic data.
Mendelian Randomization
To explore possible causal effects of GGE genome-wide loci on EEG background oscillations, we conducted Mendelian Randomization analyses using GGE and EEGs summary statistics data. 228 SNPs significantly associated with GGE (p<5x10 -8 ) were extracted from both the GGE and EEG GWASs. The summary statistics of 228 SNPs were harmonized to ensure the SNP effect direction corresponded with equal effect alleles across GGE and EEG. We used the "TwosampleMR" package (Hemani et al., 2018) in R to perform fixed effects inverse variance-weighted (IVW), weighted median, and MR Egger models. We then performed sensitivity analyses, including horizontal pleiotropic effects estimated by the intercept of MR Egger, residual heterogeneity due to pleiotropy estimated by Cochran's Q test (Burgess et al., 2015) , and leave-one-out analyses (for the IVW-fixed effect model) to evaluate if any single instrumental variable was driving the results. GSMR (generalized summary-data based mendelian randomisation) analyses were performed using the "GSMR" (Zhu et al., 2018) package in R. To that end, first the LD matrix of the selected SNPs was calculated using PLINK (Purcell et al., 2007) and GCTA (Yang et al., 2011) within 1000
Genomes Phase 3 data (Genomes Project et al., 2015) . The minimum number of instrumental variables in the GSMR model was loosened from 10 to 5 as there were only 8 independent (r 2 <0.01, LD window =10Mb), significant loci identified in the GWAS of GGE (and none in the EEG GWAS). We used default options in GSMR with Heterogeneity in Dependent Instruments (HEIDI) testing for instrumental outliers' detection. At the end, we repeated GSMR with loosened LD prune thresholds (namely r2<0.1, r2<0.15 and r2<0.2) because GSMR takes LD structure into account by adding the LD matrix. The significance threshold was Bonferroni corrected for all these seven mendelian randomisation models (p=0.05/7=0.007).
Data availability
GWASs summary statistics used for the current analyses are available online:
http://enigma.ini.usc.edu/research/download-enigma-gwas-results/;
http://www.epigad.org/gwas_ilae2018_16loci.html.
Results
Genetic correlations between epilepsy and oscillatory brain activity
In a total study population of 45,446 subjects (n=8,425 from the EEG and n=37,021 from the epilepsy GWASs), we computed genetic correlations between alpha, beta, delta and theta oscillatory brain activity with focal epilepsy and GGE. We found significant correlations between GGE and beta-power (Rg=0.44 ± s.e. of 0.18; p=0.01) and theta-power (Rg=0.25 ± 0.11; p=0.02; Figure 1 , upper panel, Supplemental table 2) ). This was further supported by the correlations between beta and theta-power with the GGE subtypes CAE, JAE and JME: all had similarly high correlation coefficients (Figure 1 , upper panel, Supplemental table 2) . We found no genetic correlations between focal epilepsy and any of the EEG phenotypes (Figure   1 , upper panel, Supplemental table 2) . We then attempted to replicate the genetic correlations using the unpublished Epi25 dataset and found similar genetic correlations (both in sign and effect size) to the discovery analyses (Figure 1, lower panel) : GGE correlated with beta power (Rg=0.52 ± 0.21, p=0.01), while the genetic correlation between theta power and GGE paralleled the discovery cohort (albeit not reaching significance: Rg=0.16 ± 0.12; p=0.18). All genetic correlation estimates with focal epilepsy were again non-significant. 
Oscillatory brain activity polygenic scores are associated with generalized epilepsy
We used polygenic scoring to utilize the full distribution of EEG oscillation-associated SNPs and assess whether people with epilepsy have a different polygenic score for specific frequency bands compared to controls. We observed significant positive associations between beta and theta-power PRSs with GGE, in line with the LDSC results (Figure 2A) . In particular beta power PRSs were strongly associated with GGE (beta=0.11; p=5.3x10 -8 ; explained variance 0.21%; Figure 2A&B) , which was further supported by significant associations of beta power PRS with its subtypes CAE (beta=0.15; p=8.5x10 -4 ) and JME (beta=0.12; p=3.6x10 -4 ). Furthermore, of the participants in the GGE case-control cohort, those in the highest 10% quantile of beta-power PRS scores were 1.4 fold more likely to have GGE compared to the people in the lowest 10% PRS quantile (OR: 1.40; 95%CI: 1.18-1.67;
p=1.5x10 -4 ; see Figure 2C ). When using the independent Epi25 cohort as a replication dataset we found that the directions of effect agreed with the discovery analyses for all associations between EEG PRSs and GGE (pone-sided= 0.023; ptwo-sided= 0.046; supplemental Figure 1 ). In line with our LDSC analyses, EEG PRSs could not explain the occurrence of focal epilepsy in our study population (all standardized beta's were non-significant and around zero). contains the 10% subjects with the highest scores. Logistic regression was used to assess whether the odds of having GGE is higher in decile 2 to 10 compared with decile 1 (reference). Sex and 10 PCs were included as covariates. Odds ratios 土 95% confidence intervals are displayed. #: P<0.05; *: P<0.001.
Meta-analysis, gene-based testing and gene expression analysis
The meta-analysis of the discovery epilepsy GGE subset and EEG GWASs yielded no novel significant loci (Supplemental figures 2 and 3) . However, brain tissue enrichment increased relative to the published epilepsy GWAS (International League Against Epilepsy Consortium on Complex, 2018). Caudate and basal ganglia constituted the primary implicated tissues in the meta-analysis (up from the fourth most enriched region in the epilepsy-only GWAS); and 3 out of the 5 most enriched tissues were now brain segments (up from 1 out of 5 in the epilepsy-only GWAS; supplemental Figure 4 ).
Moreover, using S-Predixcan we found significant associations between genetically imputed expression levels of brain-expressed genes and the GGE + beta oscillations metaanalyzed phenotype for all brain tissues. Figure 3 shows the Q-Q plots for these associations (hippocampus and frontal cortex are given as examples; Q-Q plots for the other tissues are provided in supplemental figure 5 ). Finally, relative to the GGE-only GWAS and beta oscillations GWAS, the meta-analysis showed an increased number of significantly associated genes across the brain ( Supplemental table 3) .
A B Figures 3: S-PrediXcan gene-expression effects increased in strength after meta-analyzing the original GGE
GWAS (black) with beta power (GGE + beta, red) . This resulted in many more significant discoveries than in the original GGE GWAS (FDR-corrected, dashed line; Supplemental 
Mendelian Randomization analyses
Eight GGE-associated SNPs were selected as instrumental variables at a strict LD prune threshold (r 2 <0.01, LD window =10Mb). These were used in fixed effects IVW, weighted median, MR Egger, and GSMR (r 2 <0.01) models. After loosening the LD threshold, 11 (r 2 <0.1), 12 (r 2 <0.15) and 14 (r 2 <0.2) SNPs were selected as instrumental variables for GSMR models. Causal effects of GGE loci on beta oscillations were found at the LD r 2 < 0.15 and 
Discussion
Here we leveraged the largest currently available GWASs of epilepsy and of background EEG oscillations to estimate the genetic correlation between these two traits and conduct follow-up analyses. We demonstrate a strong genetic correlation between beta and theta power with GGE. We replicated this genetic correlation in an independent epilepsy cohort that was statistically significant for beta power. Polygenic risk scoring confirmed our findings and quantified the increase in risk of suffering from genetic generalized epilepsy from the lowest to highest beta oscillations decile. Furthermore, in a meta-analysis of GGE and beta power GWASs we show that gene expression enrichment shifts towards more CNS tissues relative to the discovery epilepsy GWAS. Finally, Mendelian Randomisation analyses pointed to causal effects of genetic liability to GGE on beta power.
Previous studies comparing EEG background oscillations between epilepsy patients and controls are inconsistent: some show increased power in all frequency bands (alpha, beta, delta, theta), whereas others show only increases in specific frequency bands or even decreases in power (Clemens et al., 2000; Clemens, 2004; Clemens et al., 2007; Clemens, 2008; Tikka et al., 2013; Clemens et al., 2014) . This heterogeneity likely reflects multiple variables that are difficult to control for in clinical studies, such as AED usage, sleep deprivation, fluctuations in (inter-)ictal epileptic brain activity, EEG processing and electrode placement. We overcame such caveats by determining the genetic underpinnings of EEG frequency bands in people without epilepsy who are AED-naïve, and with a consistent electrode placement and signal processing. We applied several statistical models to assess this overlap and found that people with generalized, but not focal, epilepsy carry a relative abundance of genetic variation associated with higher theta and beta oscillations. The results are consistent with the notion that epilepsy exists on a continuum rather than as a binary state, implying that some individuals are prone to develop epileptic seizures only under certain circumstances (e.g. stroboscopic light), while others relentlessly suffer from seizures despite the use of multiple AEDs. However, prospective studies must confirm whether altered oscillatory activity could be a prodromal state of GGE. Alternatively, aberrant loading of beta oscillations on an EEG may constitute a feature of epilepsy.
We did not find genetic correlations between background EEG and focal epilepsy.
Although power was limited for this analysis, this finding is consistent with the low SNPbased heritability of focal epilepsy and the lack of genetic overlap between focal and generalized epilepsy (International League Against Epilepsy Consortium on Complex Epilepsies, 2018). A likely explanation of the lack of genetic correlation between focal epilepsy and background EEG oscillations may lie in the physiological differences between focal epilepsy and GGE. In contrast to focal epilepsy, the EEG discharges that characterize generalized epilepsy are dependent on the thalomocortical system (Gloor, 1978; Steriade and Contreras, 1998) . Background oscillations have also been functionally attributed to the thalamocortical system (Steriade et al., 1996a; Steriade et al., 1996b) and are related to functional states of the brain. Interestingly, fast oscillations have also been implicated in cognitive processes (Gray and Singer, 1989; MacKay and Mendonca, 1995) , and are also part of the sleep EEG (Steriade et al., 1996b) .
Our results should be interpreted in light of several limitations. First, we are aware of the possible advantages of using Genome Complex Trait Analysis (GCTA) relative to LDSC but since no subject-level genotype data are available for the EEG GWAS, we restricted our genetic correlation estimates to the standard LDSC method, which is based on summary statistics. Nonentheless, LDSC has proven to be a reliable method for genetic correlation estimates and results between LDSC and GCTA have proven consistent. Second, we found that alleles are shared between GGE and background EEG, but preferably prospective studies are needed to establish whether GGE patients have significant differences on their EEGs compared to controls and those with focal epilepsy. Third, only one-way Mendelian Randomisation analyses were performed due to lack of genome-wide significant loci in the EEG GWAS. We therefore cannot exclude the possibility of bidirectional causality between EEG and GGE. Fourth, we had insufficient data available to carry out subgroup analyses on subjects with non-lesional focal epilepsy patients.
Increasingly large EEG GWASs may increase power to detect pleiotropic loci and also empower pathway analyses, thus possibly providing mechanistic insight into the overlap between GGE and background EEG. Future studies may also integrate transcranial magnetic stimulation -EEG (TMS-EEG) and/or event-related potentials to examine whether beta and theta powers correlate with altered brain excitability in subjects with high epilepsy liability.
Furthermore, machine-learning studies integrating background EEG with other sources of clinical and demographic data may one day increase diagnostic accuracy of epilepsy. Finally, our findings may be followed up in clinical trials examining whether clinical decisions with a high degree of uncertainty, e.g. about if or when to start an AED in medication-naïve subjects, may be partly informed by background EEG analyses.
